Profile photo Harry Heijerman

Harry Heijerman

Full Professor

Strategic program(s):

Biography

Harry Heijerman earned his MD (1984, cum laude) and his PhD in 1991 ("Studies in the clinical management of Cystic Fibrosis") He registered as pulmonologist in 1989, all above at the Leiden University Medical School. From 1996 till 2017 he was head of the department of Pulmonology at the Haga teaching Hospital in The Hague. Since 2017 he is head of the Department of Pulmonology and professor at the University Medical Center  Utrecht The Netherlands. During his whole career he focussed on optimization of treatment for people with Cystic Fibrosis. He was PI of multiple mono and multi center studies focusing on understanding and treating Cystic Fibrosis. In 2002 he was the founding editor of the "Journal of Cystic Fibrosis". At present he is involved in several clinical studies addressing CFTR function in Cystic Fibrosis with the aim to find a cure for this life long inheritable disease, This work is done in close collaboration with the department of Pediatric Pulmonology. 

Recent publications

Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial Clinical Operations, Yasmine Yau, Elia Vitale, Giulio Vecchia, Federica D'Ambrosio, Wietske Bouwman, Marjolein van Esschoten, Frank Leus, David de Pooter, Leen Timbermont, Juan Pablo Rodriguez Ruiz, Benjamin Hommel, Marie Tessonneau, Malte Kohns Vasconcelos, Surbhi Malhotra-Kumar, Florence Allantaz, Sophie Vandepitte, Jean Louis Tissier, Philippe Cleuziat, Maarten J. Postma, Thea van Asselt, Pim van Dorst, Simon van der Pol, Fernando Antonanzas, Paula Rojas, Marino Gonzales, Dalia Dawoud, Claire Hawksworth, Mark Lyttle, Harry Heijerman, Michelle Clements, Cristina Prat Aymerich, Herman Goossens, Marc Bonten, Julia A. Bielicki, Malte Kohns Vasconcelos, Andrew Atkinson, Henri van Werkhoven, Julia A. Bielicki, Maria Simitsopoulou, Kalliopi Pantzartzi, Kostas Zarras, Argyro Ftergioti, Maria Kitsou, Aristea Karypiadou, Charis Lampada, Konstantina Charisi, Parthena Savvidou, Olga Tsiatsiou, Elsa Chorafa,
BMJ Open, 2024, vol. 14
Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy Pierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, Harry Heijerman, Andreas Jung, Jochen G Mainz, Daniel Peckham, Barry J Plant, Carsten Schwarz, Giovanni Taccetti, Alan Smyth
BMJ open respiratory research, 2024, vol. 11, p.1-9
Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study Renske van der Meer, Erik B Wilms, Margot N Eggermont, Helena M Paalvast, Matthijs van Luin, Richard C J M van Rossen, Harry G M Heijerman
Journal of Cystic Fibrosis, 2024, vol. 23, p.549-553
The influence of exocrine pancreatic function on the exposure and pharmacokinetics of ivacaftor in people with cystic fibrosis Renske van der Meer, Erik B. Wilms, Margot N. Eggermont, Helena M. Paalvast, Richard C.J.M. van Rossen, Harry G.M. Heijerman
Journal of Cystic Fibrosis, 2023, vol. 22, p.564-569
Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease Bente L. Aalbers, Firdaus A.A. Mohamed Hoesein, Regina W. Hofland, Inez Bronsveld, Marian A. Kruijswijk, Suzan Schotman, Corlien W. Slingerland, Hannah Panhuis, C. Kors van der Ent, Harry G.M. Heijerman
Pediatric Pulmonology, 2023, vol. 58, p.2317-2322
The effect of azithromycin on sputum inflammatory markers in bronchiectasis L C Terpstra, J Altenburg, H J Doodeman, Y S Sabogal Piñeros, R Lutter, H G M Heijerman, W G Boersma
BMC Pulmonary Medicine, 2023, vol. 23

Fellowships & Awards

2017: Officier in de orde van Oranje Nassau

External positions

Voorzitter adviesraad zorg - Expertise op het gebied van Cystic Fibrosis in mijn functie van longarts - Nederlandse Cystic Fibrosis stichting